140 related articles for article (PubMed ID: 22575418)
21. Variable platelet response to aspirin in patients with ischemic stroke.
Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
[TBL] [Abstract][Full Text] [Related]
23. Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery.
Arazi HC; Doiny DG; Torcivia RS; Grancelli H; Waldman SV; Nojek C; Fornari MC; Badimon JJ
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):863-7. PubMed ID: 20233808
[TBL] [Abstract][Full Text] [Related]
24. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM
Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236
[TBL] [Abstract][Full Text] [Related]
25. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
[TBL] [Abstract][Full Text] [Related]
26. Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes.
Christensen KH; Grove EL; Würtz M; Kristensen SD; Hvas AM
Platelets; 2015; 26(3):230-5. PubMed ID: 24750015
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometry.
Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
Thromb Res; 2009 Sep; 124(4):418-22. PubMed ID: 19250657
[TBL] [Abstract][Full Text] [Related]
28. Aspirin-induced platelet inhibition in patients undergoing cardiac surgery.
Zimmermann N; Kurt M; Winter J; Gams E; Wenzel F; Weber AA; Hohlfeld T
Platelets; 2007 Nov; 18(7):528-34. PubMed ID: 17957569
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
[TBL] [Abstract][Full Text] [Related]
30. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
Terres W; Schuster O; Kupper W; Bleifeld W
Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
[TBL] [Abstract][Full Text] [Related]
31. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance?
Payne DA; Jones CI; Hayes PD; Webster SE; Ross Naylor A; Goodall AH
Thromb Haemost; 2004 Jul; 92(1):89-96. PubMed ID: 15213849
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry.
Pedersen SB; Grove EL; Nielsen HL; Mortensen J; Kristensen SD; Hvas AM
Platelets; 2009 Sep; 20(6):415-20. PubMed ID: 19658002
[TBL] [Abstract][Full Text] [Related]
33. Effect of obesity on platelet reactivity and response to low-dose aspirin.
Bordeaux BC; Qayyum R; Yanek LR; Vaidya D; Becker LC; Faraday N; Becker DM
Prev Cardiol; 2010; 13(2):56-62. PubMed ID: 20377806
[TBL] [Abstract][Full Text] [Related]
34. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
[TBL] [Abstract][Full Text] [Related]
35. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
[TBL] [Abstract][Full Text] [Related]
36. Human pharmacology of naproxen sodium.
Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
[TBL] [Abstract][Full Text] [Related]
37. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
[TBL] [Abstract][Full Text] [Related]
38. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
39. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction.
Moscardó A; Santos MT; Fuset MP; Ruano M; Vallés J
Thromb Haemost; 2011 Apr; 105(4):663-9. PubMed ID: 21301784
[TBL] [Abstract][Full Text] [Related]
40. Multiple Electrode Aggregometry is an adequate method for aspirin response testing in myeloproliferative neoplasms and differentiates the mechanisms of aspirin resistance.
Gillet B; Ianotto JC; Mingant F; Didier R; Gilard M; Ugo V; Lippert E; Galinat H
Thromb Res; 2016 Jun; 142():26-32. PubMed ID: 27105311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
